Clinical Report: Comparative Evaluation of GeneXpert MTB/RIF, TB-DNA PCR, and T-SPOT.TB
Overview
This study evaluates the diagnostic performance of T-SPOT.TB, GeneXpert MTB/RIF, and TB-DNA PCR in diagnosing paucibacillary pulmonary tuberculosis (PTB).
Background
Paucibacillary pulmonary tuberculosis (PTB) poses significant diagnostic challenges due to low bacillary loads that hinder detection by conventional methods. Current molecular assays often fail to identify cases with low mycobacterial burden.
Data Highlights
Test
Sensitivity
Specificity
Balanced Accuracy
T-SPOT.TB
79.5% (95% CI 65.5–88.8%)
N/A
0.780 (0.681–0.872)
GeneXpert MTB/RIF
29.5%
0.618
N/A
TB-DNA PCR
31.8%
100%
0.659
TB-DNA PCR + T-SPOT.TB
88.6%
76.5%
0.826 (0.734–0.907)
Key Findings
T-SPOT.TB had a sensitivity of 79.5%.
The combination of TB-DNA PCR and T-SPOT.TB yielded a balanced accuracy of 0.826.
Adding all three assays did not improve diagnostic discrimination.
T-SPOT.TB was positive in 47.7% of confirmed PTB cases where other tests were negative.
GeneXpert MTB/RIF and TB-DNA PCR showed low sensitivity in smear-negative specimens.
Clinical Implications
The findings suggest that T-SPOT.TB may provide critical diagnostic information in cases of paucibacillary PTB that are missed by molecular assays. Clinicians should consider the use of T-SPOT.TB in conjunction with molecular tests for improved diagnostic accuracy.
Conclusion
This exploratory study indicates that T-SPOT.TB can enhance the diagnosis of paucibacillary PTB, warranting further investigation in larger, multicenter studies.
